- Home
- RDHL vs PBM Comparison
RDHL vs PBM Comparison
Compare RDHL & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- PBM
- Stock Information
- Founded
- RDHL 2009
- PBM 1994
- Country
- RDHL Israel
- PBM Canada
- Employees
- RDHL N/A
- PBM N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- PBM
- Sector
- RDHL Health Care
- PBM
- Exchange
- RDHL Nasdaq
- PBM NYSE
- Market Cap
- RDHL 7.5M
- PBM 7.5M
- IPO Year
- RDHL N/A
- PBM N/A
- Fundamental
- Price
- RDHL $5.64
- PBM $1.79
- Analyst Decision
- RDHL
- PBM
- Analyst Count
- RDHL 0
- PBM 0
- Target Price
- RDHL N/A
- PBM N/A
- AVG Volume (30 Days)
- RDHL 13.8K
- PBM 5.4M
- Earning Date
- RDHL 08-29-2024
- PBM 02-02-2025
- Dividend Yield
- RDHL N/A
- PBM N/A
- EPS Growth
- RDHL N/A
- PBM N/A
- EPS
- RDHL N/A
- PBM N/A
- Revenue
- RDHL $3,707,000.00
- PBM N/A
- Revenue This Year
- RDHL $224.90
- PBM N/A
- Revenue Next Year
- RDHL $82.69
- PBM N/A
- P/E Ratio
- RDHL N/A
- PBM N/A
- Revenue Growth
- RDHL N/A
- PBM N/A
- 52 Week Low
- RDHL $5.41
- PBM $1.51
- 52 Week High
- RDHL $31.50
- PBM $593.25
- Technical
- Relative Strength Index (RSI)
- RDHL 35.38
- PBM 39.22
- Support Level
- RDHL $5.41
- PBM $1.61
- Resistance Level
- RDHL $5.79
- PBM $2.25
- Average True Range (ATR)
- RDHL 0.31
- PBM 0.22
- MACD
- RDHL -0.05
- PBM 0.06
- Stochastic Oscillator
- RDHL 14.26
- PBM 23.38
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.